Key Insights

Highlights

Treatment Research

2 treatments under study, led by Phenterminetopiramate Er

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07790913Phase 2Not Yet Recruiting

Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma

Showing all 1 trials

Research Network

Common Treatments

  • Phenterminetopiramate Er1
  • Health Behavior And Lifestyle Counseling1

Active Sponsors

  • St. Jude Children's Research Hospital1

Top Investigators

Related Conditions

  • Cancer Survivorship1
  • Acute Lymphoblastic Leukemia In Remission1
  • Hodgkin Lymphoma In Remission1

Activity Timeline